Cargando…

The Evaluation of Determinants and Impacts of Co-Production in Healthcare: A Research Protocol for OPAT in Cystic Fibrosis

INTRODUCTION: Co-production is more and more considered as a promising tool for dealing with the main challenges in the health sector (e.g., growing rates of chronic diseases, budget constraints, higher patients’ expectations of the quality and the value of services, equity to access of care, etc.)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Marsilio, Marta, Gramegna, Andrea, Fusco, Floriana, Gheduzzi, Eleonora, Pizzamiglio, Giovanna, Blasi, Francesco, Guglielmetti, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2021
Materias:	Methodology Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086733/ https://www.ncbi.nlm.nih.gov/pubmed/33981192 http://dx.doi.org/10.5334/ijic.5568

Ejemplares similares

Co-Production Performance Evaluation in Healthcare. A Systematic Review of Methods, Tools and Metrics
por: Marsilio, Marta, et al.
Publicado: (2021)

Co-production in health policy and management: a comprehensive bibliometric review
por: Fusco, Floriana, et al.
Publicado: (2020)

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)

Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry
por: Gambazza, Simone, et al.
Publicado: (2023)

An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis
por: Hoo, Zhe H, et al.
Publicado: (2017)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”
por: Hoo, Zhe Hui, et al.
Publicado: (2016)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021)

Managing Cystic Fibrosis in Polish Healthcare
por: Rachel, Marta, et al.
Publicado: (2020)

Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis
por: Le Gall, Florence, et al.
Publicado: (2013)

Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis
por: Rowbotham, N. J., et al.
Publicado: (2019)

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW
por: Gramegna, Andrea, et al.
Publicado: (2018)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

Facilitating OPAT in rural areas
por: Mehta, Meera, et al.
Publicado: (2023)

Exploring the advancements of Australian OPAT
por: Lai, Tony, et al.
Publicado: (2023)

Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
por: Denford, Sarah, et al.
Publicado: (2020)

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

When and how ruling out cystic fibrosis in adult patients with bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2018)

P13 Every patient who could have OPAT, should have OPAT—the importance of data
por: Williams, Steph, et al.
Publicado: (2022)

A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways
por: Wijers, Christiaan D. M., et al.
Publicado: (2016)

Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: a survey of Italian CF centers
por: Borchi, Beatrice, et al.
Publicado: (2018)

1934. Who Really Benefits Financially From OPAT: Patients/Families or Healthcare Institutions?
por: Ibrahim, Laila, et al.
Publicado: (2018)

Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients
por: Deschaght, Pieter, et al.
Publicado: (2009)

1300 OPAT Administration in the Homeless Population
por: Hernandez, Whitney, et al.
Publicado: (2014)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

339. OPAT Outcomes in Patients with Immunocompromise
por: Mahoney, Monica V, et al.
Publicado: (2023)

Being ‘at-home’ on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents’ experiences of paediatric OPAT
por: Carter, Bernie, et al.
Publicado: (2020)

Telemonitoring: An opportunity in cystic fibrosis lung transplant recipients
por: Corinna Morlacchi, Letizia, et al.
Publicado: (2023)

Liver Disease in Cystic Fibrosis: an Update
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2013)

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2023)

1923. OPAT or No-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
por: Britt, Rachel S, et al.
Publicado: (2018)

Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists
por: Volpi, Sonia, et al.
Publicado: (2022)

Spustenie hadrónového urýchľovača častíc opäť posunuli
Publicado: (2008)

Spustenie hadrónového urýchľovača častíc opäť posunuli
Publicado: (2008)

OPATs: Omnibus P-value association tests
por: Chen, Chia-Wei, et al.
Publicado: (2017)

Clinical outcomes of teicoplanin use in the OPAT setting
por: Dabrowski, Hannah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dvh2f1fiuopa0qj2gabjsqc9hb